Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1832526 (
PCC
)
5,967
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
S-(3, 4-dichlorobenzyl) isothiourea (A22) has been reported to specifically inhibit the function of MreB, an
actin-like protein
in rod-shaped bacteria. This study investigated the role of A22 in cyanobacterium Anabaena sp. strain
PCC
7120, which can form nitrogen-fixing heterocysts under combined-nitrogen deprivation. Results indicated that A22 could inhibit cell growth, cause abnormal cellular morphology and bring about asymmetric cell division and irregular DNA distribution. However, A22 has little effect on heterocyst formation. An A22-resistant mutant named C23 was isolated by growing cells on A22-containing plates. It had normal appearance of cell shape, division and DNA content when treated by A22. However, this mutant retained a wild-type allele of mreB.
...
PMID:Effects of S-(3,4-dichlorobenzyl) isothiourea on different cellular events in the cyanobacterium Anabaena sp. strain PCC 7120. 2132 May 91